Cargando…
Potential of transposon-mediated cellular reprogramming towards cell-based therapies
Induced pluripotent stem (iPS) cells present a seminal discovery in cell biology and promise to support innovative treatments of so far incurable diseases. To translate iPS technology into clinical trials, the safety and stability of these reprogrammed cells needs to be shown. In recent years, diffe...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415244/ https://www.ncbi.nlm.nih.gov/pubmed/32843912 http://dx.doi.org/10.4252/wjsc.v12.i7.527 |